Literature DB >> 6208827

Biochemical and serologic properties of Escherichia coli isolated from cows with acute mastitis.

V Sanchez-Carlo, R A Wilson, J S McDonald, R A Packer.   

Abstract

Biochemical and serologic characteristics of 184 Escherichia coli isolates from cows with acute mastitis were determined. Trends or patterns unique to bovine isolates were not observed, except for the frequency of adonitol fermentation, which was positive in 84 (45.6%) of the cultures. Growth on Tergitol-7 agar had 3 types of colony morphologic characteristics; of these, the rough and intermediate textures predominated over those with smooth colony surfaces. A large variety of serovars was detected; the majority occurring as single isolates within a herd. Few K antigens were typeable. Only 2 isolates contained the K99 antigen. Seemingly, E coli organisms isolated from cows with acute mastitis cannot be distinguished as a specific pathogenic group on the basis of biochemical and serotest reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208827

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Adaptation of Escherichia coli to the bovine mammary gland.

Authors:  A J Bradley; M J Green
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Identification of Escherichia coli recovered from milk of sows with coliform mastitis by random amplified polymorphic DNA (RAPD) using standardized reagents.

Authors:  P Ramasoota; K Krovacek; N Chansiripornchai; A P Mörner; S B Svenson
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

3.  Association of Escherichia coli J5-specific serum antibody responses with clinical mastitis outcome for J5 vaccinate and control dairy cattle.

Authors:  David J Wilson; Bonnie A Mallard; Jeanne L Burton; Ynte H Schukken; Yrjo T Grohn
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

Review 4.  Progress towards the Elusive Mastitis Vaccines.

Authors:  Pascal Rainard; Florence B Gilbert; Rodrigo P Martins; Pierre Germon; Gilles Foucras
Journal:  Vaccines (Basel)       Date:  2022-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.